Using a Delphi process to determine optimal care for patients with pancreatic cancer

Asia-Pacific Journal of Clinical Oncology
Elizabeth A BurmeisterPancreatic Cancer Clinical Working Group

Abstract

Overall 5-year survival for pancreatic cancer is ∼5%. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scores were calculated and categorized into three levels of importance. Overall, 63 (66% of those sent the final questionnaire; 25% of those initially invited) health professionals from nine disciplines completed the final scoring of 55 statements/factors encompassing themes of presentation/staging, surgery and biliary obstruction, multidisciplinary team details and oncology. Mean scores ranged from 3.7 to 9.7 with the highest related to communication and patient assessment. There was substantial intra- and interdisciplinary variation in views about MDT membe...Continue Reading

References

Jan 1, 1996·British Journal of Cancer·J CarmichaelJ Blatter
Nov 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R.Y. Kim
May 13, 2005·Gut·UNKNOWN Pancreatric Section, British Society of GastroenterologyUNKNOWN Special Interest Group for Gastro-Intestinal Radiology
Oct 10, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VerslypeJ Zalcberg
Nov 22, 2007·Journal of General Internal Medicine·Teryl K NuckolsSteven Asch
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S CascinuUNKNOWN ESMO Guidelines Working Group
Jun 3, 2011·The New England Journal of Medicine·Jonathan F FinksJohn D Birkmeyer
Aug 5, 2011·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Jaswinder S SamraThomas J Hugh
Nov 16, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Nicolò PecorelliMarco Braga
Nov 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M M VickersM J Moore
Dec 14, 2011·Asia-Pacific Journal of Clinical Oncology·UNKNOWN Australian Institute of Health and Welfare
Sep 20, 2012·Journal of Surgical Oncology·Elan R WitkowskiJennifer F Tseng
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T SeufferleinUNKNOWN ESMO Guidelines Working Group
Oct 26, 2012·The New England Journal of Medicine·Jane C WeeksDeborah Schrag
Oct 26, 2012·ANZ Journal of Surgery·Neil WylieUNKNOWN Queensland Pancreatic Cancer Study Group
Dec 11, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Josep M BorrasRobin Wilson
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Aug 19, 2014·World Journal of Gastroenterology : WJG·Trond A Buanes
Sep 30, 2015·BMC Health Services Research·Natalie K BradfordAnthony C Smith
Oct 29, 2015·Australian Journal of Primary Health·Louise FreijserMeinir Krishnasamy

❮ Previous
Next ❯

Citations

Jul 5, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·E A BurmeisterR E Neale
Mar 25, 2018·Asia-Pacific Journal of Clinical Oncology·Monica I DumbravaRachel E Neale
Nov 18, 2016·The Medical Journal of Australia·Elizabeth A BurmeisterRachel E Neale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.